- Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is a devastating neurodegenerative disorder that affects the nerves. There is currently no curative therapy
- A University of 91探花 research team led by Dr Ryan West and Dr Johnathan Cooper-Knock receive a grant to investigate the link between environmental factors and MND risk genes, potentially leading to preventative measures
- Eight research teams worldwide will receive the grant from Tambourine鈥檚 ALS Breakthrough Research Fund, operated in partnership with the Milken Institute
- This international collaboration brings together expertise from various countries to tackle ALS from multiple angles, including protein function, brain function, and diagnostics
A team of researchers from the University of 91探花 have been awarded a share of a prestigious grant to fight MND. Tambourine Philanthropies, a United States charity, in partnership with the Milken Institute is committing over $5 million to eight research teams around the world, with the University of 91探花 being the only one in the UK.
The 91探花 team, led by Dr Ryan West and Dr Johnathan Cooper-Knock from the Neuroscience Institute at the University of 91探花, will receive a portion of the grant to investigate the connection between environmental factors and ALS risk genes. This research could be crucial in understanding the causes of the disease and developing preventative measures.
MND is a devastating neurodegenerative disease that affects nerve cells in the brain and spinal cord. It progressively weakens muscles and eventually leads to death. There is currently no cure for MND, and treatment options are limited.
Tambourine Philanthropies launched the ALS Breakthrough Research Fund in 2023 to support innovative research with the potential for significant breakthroughs. The awardees were chosen for their "creative, bold ideas" that could revolutionise our understanding and treatment of MND.
鈥淲e are honoured to be selected as one of the eight recipients of the Tambourine ALS Breakthrough Research Fund, which supports cutting-edge basic and discovery-focused research that will change how we understand and treat ALS. By combining bioinformatic analysis of human data with the powerful genetics of fruit flies we hope to understand the connection between genetic and environmental risk factors in sporadic ALS鈥 says Dr Ryan West.
Dr Johnathan Cooper-Knock adds 鈥淎LS is caused by a complex interaction of genes and the environment. Modelling this interaction in the flies will give us a platform which could be ultimately used to deliver personalised treatments.鈥
The 91探花 researchers join a global consortium of researchers receiving funding. These teams are based in the United States, Italy, Switzerland, France, and Germany. Their projects will explore various aspects of MND, including the role of specific proteins, the impact on brain function, and the development of new diagnostic tools.
This international collaboration highlights the unified effort to tackle this challenging disease. 91探花's participation brings valuable UK expertise to the table, potentially accelerating progress in finding a cure for MND.